Month: September 2018

The Opioid Crisis Response Act falls short of curtailing Big Pharma’s stake in opioids. On September 17, 2018, a new opioid bill known as The Opioid Crisis Response Act, geared towards Big Pharma, passed with an unprecedented 99 to 1 in the Senate. The bill seems to be more of...

Read More >

Cost Savings of Medical Marijuana has more to do with why pharmaceutical companies are fighting legal marijuana than any other reason they advertise. There’s a body of research showing that painkiller abuse and overdose are lower in states with medical marijuana laws. These studies have generally assumed that when medical marijuana is available,...

Read More >